Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

SLAM-SAP Signaling Promotes Differentiation of IL-17-Producing T Cells and Progression of Experimental Autoimmune Encephalomyelitis.
Quantifying progression of multiple sclerosis via classification of depth videos.
TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3(+) Treg cells.
Naturally Occurring Antibodies as Therapeutics for Neurologic Disease : Can Human Monoclonal IgMs Replace the Limited Resource IVIG?
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials.
Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis.
The CD27 and CD70 Costimulatory Pathway Inhibits Effector Function of T Helper 17 Cells and Attenuates Associated Autoimmunity.
Increased Plasma Interleukin-32 Expression in Patients with Neuromyelitis Optica.
Adapted exercise interventions for persons with progressive multiple sclerosis.
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid and the diagnosis of multiple sclerosis.
Relevance of Spinal Cord Abnormalities to Clinical Disability in Multiple Sclerosis: MR Imaging Findings in a Large Cohort of Patients.
Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Failed Concept.
Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester.
1,25-Dihydroxyvitamin D3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis.
Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.
Acute optic neuritis: Unmet clinical needs and model for new therapies.
Application of multispectral imaging detects areas with neuronal myelin loss, without tissue labelling.
Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP).
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
Status migrainosus as an initial presentation of multiple sclerosis.
Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7β-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of α-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3).
Time-efficient, high-resolution, whole brain three-dimensional macromolecular proton fraction mapping.
Multiple sclerosis is primarily a neurodegenerative disease.
Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort.

Pages